The United Laboratories Stock Beta
| ULIHFDelisted Stock | USD 1.09 0.00 0.00% |
The United Laboratories fundamentals help investors to digest information that contributes to United Laboratories' financial success or failures. It also enables traders to predict the movement of United Pink Sheet. The fundamental analysis module provides a way to measure United Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to United Laboratories pink sheet.
United |
The United Laboratories Company Beta Analysis
United Laboratories' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current United Laboratories Beta | 0.3 |
Most of United Laboratories' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The United Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CompetitionIn accordance with the recently published financial statements, The United Laboratories has a Beta of 0.2952. This is 65.67% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The beta for all United States stocks is notably lower than that of the firm.
United Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses United Laboratories' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of United Laboratories could also be used in its relative valuation, which is a method of valuing United Laboratories by comparing valuation metrics of similar companies.United Laboratories is currently under evaluation in beta category among its peers.
As returns on the market increase, United Laboratories' returns are expected to increase less than the market. However, during the bear market, the loss of holding United Laboratories is expected to be smaller as well.
United Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0539 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 850.36 M | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 50.35 % | |||
| Shares Owned By Institutions | 8.56 % | |||
| Price To Earning | 8.47 X | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 9.7 B | |||
| Gross Profit | 4.21 B | |||
| EBITDA | 1.26 B | |||
| Net Income | 988.1 M | |||
| Cash And Equivalents | 4.04 B | |||
| Cash Per Share | 2.22 X | |||
| Total Debt | 221.21 M | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 5.36 X | |||
| Cash Flow From Operations | 1.54 B | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 13.6 K | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.29 B | |||
| Total Asset | 16.33 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 16.33 B | |||
| Last Dividend Paid | 0.13 |
About United Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The United Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of United Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The United Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in United Pink Sheet
If you are still planning to invest in The United Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the United Laboratories' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |